Pharmacogenetic Testing
Pharmacogenetic Testing Without a Doctor's Order: Your Options
GeneSight and Genomind require a clinician to place the order. If that is a barrier, direct-to-consumer services that work with existing 23andMe or AncestryDNA data deliver the same core pharmacogenetic information for $5 to $49 without a prescriber.
Most well-known pharmacogenetic tests like GeneSight and Genomind require a healthcare provider to place the order. That is a barrier for a lot of people. Maybe your doctor is not familiar with pharmacogenetics, your insurance will not cover a visit to a specialist who offers it, or you just want the information without jumping through hoops. There are options for getting pharmacogenetic insights without needing a doctor's order upfront.
$5 to $49 cost of a pharmacogenetic report from your existing genetic data, versus several hundred dollars or more for a clinician-ordered clinical test
Why the provider requirement exists and how to work around it
Why most clinical PGx tests require a doctor
GeneSight, Genomind, and similar tests are classified as clinical laboratory tests. By regulation and company policy, they require a licensed provider to order them. That makes sense for test-and-treat scenarios, but it creates an access problem for people who just want to know their pharmacogenetic profile in advance. Not every doctor is comfortable ordering PGx tests, and not every patient has easy access to one who is.
Your existing genetic data is already yours
If you have already taken a 23andMe, AncestryDNA, or whole-genome sequencing test, you own that data. It contains the same pharmacogenetic variants that clinical tests analyze. Consumer genotyping arrays are not clinical-grade assays and the raw data files are labeled 'not for medical use', but they reliably capture the core pharmacogenetic variants covered by CPIC guidelines. Services that interpret your existing data do not need a doctor's order because they are not running a new lab test.
Direct-to-consumer PGx services exist
Several services, including Gene2Rx, offer pharmacogenetic analysis directly to consumers. Gene2Rx analyzes raw genetic data files you upload from 23andMe, AncestryDNA, or a VCF. You get a report covering how your genetics affect your response to over 110 medications, for $5 to $49, without anyone having to place the order for you.
The information is still most useful with a doctor
You do not need a doctor to get pharmacogenetic testing, but the results are most useful when shared with your healthcare provider. A pharmacogenetic report tells you how your body metabolizes medications. Turning that into a specific prescribing decision needs clinical context only your doctor has. Think of it as bringing data to a conversation, not replacing the conversation.
You do not need a doctor to get pharmacogenetic testing, but the results are most useful when shared with your healthcare provider.
How your genetics can play a role
Whether you get pharmacogenetic testing through a doctor or directly, the same core genes are analyzed. Knowing what they do helps explain why the information is worth having.
| Gene | What it affects |
|---|---|
| CYP2D6 | Metabolizes many antidepressants, ADHD medications (atomoxetine), pain medications (codeine, tramadol), tamoxifen, and beta-blockers.[2] About 5 to 10 percent of people are poor metabolizers who process these drugs too slowly, and 1 to 2 percent are ultrarapid metabolizers who clear them too fast. |
| CYP2C19 | Metabolizes SSRIs (sertraline, escitalopram, citalopram),[3] clopidogrel (Plavix),[4] and proton pump inhibitors (omeprazole). Variations affect about 30 percent of people meaningfully. |
| CYP2C9 + VKORC1 | Together these determine your warfarin dose sensitivity.[5] Nearly 50 percent of people carry variants in one or both genes. Also relevant for NSAID metabolism (CYP2C9). |
| SLCO1B1 | Determines statin muscle pain risk.[6] About 15 to 20 percent of people carry the variant that increases susceptibility. |
The core pharmacogenetic science is standardized across testing services. CPIC (Clinical Pharmacogenetics Implementation Consortium) publishes evidence-based guidelines that map genotypes to prescribing recommendations.[1] Those guidelines apply whether your test was ordered by a doctor or run on your existing data. What matters is the accuracy of the genotyping and how closely the interpretation follows the guidelines.
Want to know what your genetics say about how you'll respond to Sertraline?
A Gene2Rx report reads your own DNA to show how it may affect your response to Sertraline and your other medications.
Find out todayWhen to consider pharmacogenetic testing
Direct-to-consumer pharmacogenetic testing is a good fit if you already have 23andMe or AncestryDNA data and want to pull the PGx information out of it, if your doctor does not offer or is not familiar with pharmacogenetic testing, if you want to understand your drug metabolism before you need a specific medication, or if cost is a concern and you want to avoid the price of clinical PGx tests.
What you can do next
- Check if you already have genetic data from 23andMe, AncestryDNA, or another testing service.
- If you do, download your raw data file and upload it to Gene2Rx for a pharmacogenetic report.
- If you do not have existing data, consider whether a 23andMe or AncestryDNA test makes sense. They are affordable, and the raw data is usable for PGx analysis on top of the ancestry and trait results.
- Once you have your pharmacogenetic report, bring it to your next doctor's appointment. Most providers are glad to have the information, even if they did not order the test themselves.
Related medications
Related guides
- 23andMe Pharmacogenetics: How to Get a Drug Response Report From Your Existing Data
- AncestryDNA for Drug Testing: Get Pharmacogenetics From Your Ancestry Data
- MyHeritage Pharmacogenetics: Use Your MyHeritage DNA for a Drug Response Report
- Nebula Genomics Pharmacogenetics: How to Get a Drug Response Report From Your WGS Data
- How Much Does a Pharmacogenetic Test Cost? 2026 Prices and Cheaper Alternatives
- SelfDecode Alternative: Comparing Genetic Health Report Options
Frequently asked questions
Is direct-to-consumer pharmacogenetic testing as accurate as doctor-ordered tests?
The pharmacogenetic guidelines (CPIC, FDA) are the same. The accuracy of the variant calls depends on the genotyping platform. Consumer arrays from 23andMe and AncestryDNA are reliable for the core pharmacogenetic variants but are not clinical-grade assays, and the raw data is not for medical use. Clinical tests run in CLIA-accredited labs can also detect structural variants like CYP2D6 gene duplications that consumer chips miss. For most prescribing questions a direct-to-consumer report is a strong starting point. One real difference: doctor-ordered tests sometimes include genetic counseling or follow-up support, which you would arrange separately with DTC testing.
Will my doctor accept results from a non-clinical PGx test?
Most doctors will review pharmacogenetic information regardless of source, especially if the report clearly cites established guidelines like CPIC. Some will want to confirm specific results with a clinical test before making prescribing changes, which is a reasonable approach for high-stakes medications like warfarin or clopidogrel.
Can I get pharmacogenetic testing if I don't have 23andMe or AncestryDNA?
Yes. You could take a 23andMe or AncestryDNA test first (the most affordable route to raw genetic data), or explore clinical PGx services that offer telehealth provider orders. Gene2Rx works with any raw genetic data in standard formats.
References
- Clinical Pharmacogenetics Implementation Consortium (CPIC). CPIC Guidelines. cpicpgx.org
- U.S. Food and Drug Administration. Table of Pharmacogenomic Biomarkers in Drug Labeling (2024). fda.gov
- CPIC. CPIC Guideline for SSRI and SNRI Antidepressants and CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A (2023). cpicpgx.org
- CPIC. CPIC Guideline for Clopidogrel and CYP2C19 (2022). cpicpgx.org
- CPIC. CPIC Guideline for Pharmacogenetics-Guided Warfarin Dosing (CYP2C9, VKORC1, CYP4F2) (2017). cpicpgx.org
- CPIC. CPIC Guideline for Statins and SLCO1B1, ABCG2, and CYP2C9 (2022). cpicpgx.org
Disclaimer: This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before making changes to your medication. Never stop or change a medication without medical supervision.